Vaccine Company, Inc.
Quick facts
Marketed products
- COVID-19 mRNA vaccine · Immunology / Infectious Disease
The vaccine delivers mRNA encoding the SARS-CoV-2 spike protein, which is translated by host cells to trigger adaptive immune responses against COVID-19.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: